Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
22.07.2020
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More Topics Petrovax Pharm
17.04.2020
Komsomolskaya Pravda newspaper compiled a social responsibility ranking of Russian billionaires and the corporations they lead. Vladimir Potanin is ranked at the top with a wide margin from everyone who actively joined the fight against the epidemic.
More Topics Vladimir Potanin
17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More Topics Petrovax Pharm
09.04.2020
Last year Petrovax, a pharmaceutical company, achieved great progress, demonstrating excellent performance and adopting a new development strategy.
More
01.04.2020
Previously, in the role of the Senior Vice President, he was in charge of sales, procurement, and innovation at MMC Norilsk Nickel.
More Topics Interros